Malignant Oropharyngeal Neoplasm — Trials

Malignant Oropharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 143
Recruiting: 77
Ph III recruiting: 7
Growth YoY: −7.7%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 151–171 of 171 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01439724	Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients	completed	Phase 3	94	Instituto Nacional de Cancer, BrazilOTHER_GOV	1	Apr 11, 2014	clinicaltrials
NCT01358097	Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy	completed	—	33	Icahn School of Medicine at Mount SinaiOTHER	1	Apr 10, 2014	clinicaltrials